分享好友 供应首页 频道列表
1/5
CD133 antibody图1

CD133 antibody

2022-01-20 15:474130询价
价格:￥3800.00/支
品牌:Biorbyt
起订:1支
供应:3000支
发货:7天内
发送询价
Product Overview
Product Name CD133 antibody
Catalog Number orb99113
Species/Host Rabbit
Reactivity Human, Mouse, Rat
Conjugation Unconjugated
Custom conjugations  
Tested applications ELISA, ICC, IF, IHC-P, WB
Immunogen

KLH conjugated synthetic peptide derived from human CD133. Please contact us for the exact immunogen sequence. The peptide is available as orb374954.
Target CD133. Human;Mouse;Rat. No cross reactivity with other proteins.
Alternative Names (click to expand)
Product Properties
Form/Appearance 10 mM PBS, 0.02% sodium azide, 10 mg/ml BSA
Concentration

- 100 μg (in 100 μl): 1 mg/ml
- 200 μg (in 200 μl): 1 mg/ml
Storage After reconstitution store at 4°C.for up to two weeks. For long term storage, aliquot and store at -20°C. Avoid freeze/thaw cycles.
Note For research use only.
Isotype IgG
Clonality Polyclonal
Purity

Polyclonal antibodies are purified by peptide affinity chromatography
MW 95 kDa
Uniprot ID

O43490 (Human); O54990 (Mouse)
NCBI NP_001139319.11; NM_001145847.11
Entrez 8842
Product Description
Application Notes
Dilution Range IHC-P:1:200, WB: 1:500, IF/ICC: 1:200

References

 

  1. Sun, Z. et al. Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours. oncol Lett 20, 341 (2020)
  2. Liao, C. H. et al. Restoration of erectile function with intracavernous injections of endothelial progenitor cells after bilateral cavernous nerve injury in rats. Andrology 3, 924-932 (2015)
  3. Tu, Z. et al. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. Int. J. Oncol. 50, 505-514 (2017)
  4. Feng, L. et al. Isolation and phenotypic characterization of cancer stem-like side population cells in colon cancer. Mol Med Rep 12, 3531-3536 (2015)
  5. Kase, M. et al. Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme. Radiol Oncol 47, 405-410 (2013)
  6. Nel, I. et al. Circulating Tumor Cell Composition in Renal Cell Carcinoma. PLoS ONE 11, e0153018 (2016)
  7. Yang, M. et al. An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior. J. Biomed. Mater. Res. Part B Appl. Biomater. 103, 618-628 (2015)
  8. Zou, Y. et al. Nrf2 is involved in maintaining hepatocyte identity during liver regeneration. PLoS ONE 9, e107423 (2014)
  9. Zhu, Y. et al. Influence of interferon-? on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Exp. Cell Res. 324, 146-156 (2014)
  10. Nowacki, M. et al. Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis. Oncotarget 6, 22776-22798 (2015)
  11. Nadal, R. et al. CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int. J. Cancer 133, 2398-2407 (2013)
  12. Winardi, D. et al. Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma. Biomed Res Int 2014, 723176 (2014)
  13. Jensen, T. et al. Descriptive analysis of tumor cells with stem like phenotypes in metastatic and benign adrenal tumors. J. Pediatr. Surg. 50, 1493-1501 (2015)
  14. Hirashima, K. et al. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture. Cell Tissue Res., (2018)
  15. IHC-P analysis of human muscle tissue using CD133 antibody (Primary antibody diluted to 1:100)
    IHC-P analysis of human muscle tissue using CD133 antibody (Primary antibody diluted to 1:100)
    IHC-P analysis of human lung cancer tissue using CD133 antibody (Primary antibody diluted to 1:100)
    IHC-P analysis of human lung cancer tissue using CD133 antibody (Primary antibody diluted to 1:100)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded human colo<em></em>nic adenocarcinoma tissue using CD133 antibody (Dilution of primary antibody 1:100)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded human colonic adenocarcinoma tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IHC-P analysis of human muscle tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of human muscle tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of human colo<em></em>nic adenocarcinoma tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of human colonic adenocarcinoma tissue using CD133 antibody (Primary antibody at 1:100)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded human muscle tissue using CD133 antibody (Primary antibody diluted to 1:200)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded human muscle tissue using CD133 antibody (Primary antibody diluted to 1:200)
    IHC-P analysis of human lung cancer tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IHC-P analysis of human lung cancer tissue using CD133 antibody (Dilution of primary antibody 1:100)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded mouse skin tissue using CD133 antibody (Dilution of primary antibody 1:100)
    Immunohistochemical analysis of formalin-fixed and paraffin embedded mouse skin tissue using CD133 antibody (Dilution of primary antibody 1:100)
    Immunofluorescent analysis of mouse brain tissue using CD133 antibody (Primary antibody diluted to 1:200)
    Immunofluorescent analysis of mouse brain tissue using CD133 antibody (Primary antibody diluted to 1:200)
    IHC-P analysis of mouse brain tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IHC-P analysis of mouse brain tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IHC-P analysis of mouse heart tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of mouse heart tissue using CD133 antibody (Primary antibody at 1:100)
    Immunohistochemical staining of paraffin embedded human breast cancer tissue using anti-CD206 (primary antibody at 1:200)
    Immunohistochemical staining of paraffin embedded human breast cancer tissue using anti-CD206 (primary antibody at 1:200)
    IHC-P analysis of mouse liver tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of mouse liver tissue using CD133 antibody (Primary antibody at 1:100)
    IHC-P analysis of mouse liver tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IHC-P analysis of mouse liver tissue using CD133 antibody (Dilution of primary antibody 1:100)
    IF analysis analysis of mouse lung tissue using CD133 antibody (Dilution of primary antibody 1:200)
    IF analysis analysis of mouse lung tissue using CD133 antibody (Dilution of primary antibody 1:200)
    Western Blot on human cells using CD133 antibody (Protocol steps under Review A) [Reviews]
    Western Blot on human cells using CD133 antibody (Protocol steps under Review A) [Reviews]
    WB analysis of rat small intestine tissue using CD133 antibody (dilution at 1:200-1:1000 ba<em></em>sed on 1mg/mL)
    WB analysis of rat small intestine tissue using CD133 antibody (dilution at 1:200-1:1000 based on 1mg/mL)
    Western blot analysis of human cancer cell lysates using CD133 antibody [Reviews]
    Western blot analysis of human cancer cell lysates using CD133 antibody [Reviews]
反对 0
举报 0
收藏 0
联系方式